Abstract Topics

  • Myelodysplastic syndrome (MDS)  & acute myeloid leukemia (AML) – translational perspectives
  • Myelodysplastic syndrome (MDS)  & acute myeloid leukemia (AML) – diagnostic aspects
  • Myelodysplastic syndrome (MDS)  & acute myeloid leukemia (AML) – treatment perspectives: personalized treatments, controversies and cure
  • Myelodysplastic syndrome (MDS)  & acute myeloid leukemia (AML) – the role of minimal residual disease (MRD)
  • Myelodysplastic syndrome (MDS)  & acute myeloid leukemia (AML) – age adapted clinical approach 
  • Myelodysplastic syndrome (MDS)  & acute myeloid leukemia (AML) – clinical trials
  • Acute lymphoblastic leukemia (ALL) – translational perspectives
  • Acute lymphoblastic leukemia (ALL) – diagnostic aspects
  • Acute lymphoblastic leukemia (ALL) – treatment perspectives: personalized treatments, controversies and cure
  • Acute lymphoblastic leukemia (ALL) – the role of minimal residual disease (MRD)
  • Acute lymphoblastic leukemia (ALL) – age adapted clinical approach
  • Acute lymphoblastic leukemia (ALL) – clinical trials
  • Myeloproliferative disorders (MPD) & Chronic myeloid leukemia (CML) – translational perspectives
  • Myeloproliferative disorders (MPD) & Chronic myeloid leukemia (CML) – diagnostic aspects
  • Myeloproliferative disorders (MPD) & Chronic myeloid leukemia (CML) – treatment perspectives: personalized treatments, controversies and cure
  • Myeloproliferative disorders (MPD) & Chronic myeloid leukemia (CML) – age adapted clinical approach
  • Myeloproliferative disorders (MPD) & Chronic myeloid leukemia (CML) – clinical trials 
  • Chronic lymphocytic leukemia (CLL) – translational perspectives
  • Chronic lymphocytic leukemia (CLL) – diagnostic aspects
  • Chronic lymphocytic leukemia (CLL) –  treatment perspectives: personalized treatments, controversies and cure
  • Chronic lymphocytic leukemia (CLL) – the role of minimal residual disease (MRD)
  • Chronic lymphocytic leukemia (CLL) – age adapted clinical approach
  • Chronic lymphocytic leukemia (CLL) – clinical trials
  • Interdisciplinary perspectives and patient reported outcomes (PROs) in acute and chronic leukemias
  • Immunological perspectives in the treatment of acute and chronic leukemia

To submit and abstract, please CLICK HERE.